Please assess the completion status of the following clinical trial:

Trial Title: The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive Candidiasis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
* Diagnosis of candidemia and/or other forms of invasive candidiasis.~* Should not have received greater than 48 hours of systemic antifungal therapy.~* Life expectancy should be greater than 72 hours.~* Should not have received greater than one week of prophylactic azole therapy 30 days prior to enrollment

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).